-

Reinsurance Group of America Announces Longevity Reinsurance Transaction With Athora Netherlands

AMSTERDAM--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA) a leading global life and health reinsurer, today announced the completion of a longevity reinsurance transaction with Athora Netherlands, a leading pension provider in the Dutch market. The reinsurance transaction covers an inforce portfolio of approximately 46 thousand individual annuity polices written by Athora in the Netherlands with total reserves of approximately EUR 3.3 bln. Under this reinsurance agreement, the longevity risk is transferred to RGA over the full remaining term of the underlying portfolio.

“We are very pleased to have worked with Athora to complete this transaction. This deal is representative of the guiding principles of RGA – to work closely with our clients and partners to develop customized solutions to help them address financial challenges and position themselves for future growth,” said Olav Cuiper, Executive Vice President, Head of RGA EMEA. “We are actively working to grow our longevity business in continental Europe, and we are proud to build on our past groundbreaking transactions in the Netherlands and France and our strong franchise in the U.K.”

“By collaborating with RGA, we were able to use their local market knowledge and global expertise to build an attractive solution to meet our risk capital and management goals,” said Etienne Comon, Chief Capital & Investment Officer, Athora Netherlands. “Our strong partnership with RGA made the process smooth and beneficial for both parties.”

The transaction closed on July 1, 2021 and is effective since then. Additional terms of the transaction are not being disclosed.

About RGA

Reinsurance Group of America, Incorporated (RGA), a Fortune 500 company, is among the leading global providers of life reinsurance and financial solutions, with approximately $3.5 trillion of life reinsurance in force and assets of $88.9 billion as of June 30, 2021. Founded in 1973, RGA is recognized for its deep technical expertise in risk and capital management, innovative solutions, and commitment to serving its clients. With headquarters in St. Louis, Missouri, and operations around the world, RGA delivers expert solutions in individual life reinsurance, individual living benefits reinsurance, group reinsurance, health reinsurance, facultative underwriting, product development, and financial solutions. To learn more about RGA and its businesses, visit the company’s website at www.rgare.com.

Contacts

Lynn Phillips
Vice President, Corporate Communications
636-736-2351
lphillips@rgare.com

Lizzie Curry
Director, Public Relations
636-736-8521
lizzie.curry@rgare.com

Jeff Hopson
Senior Vice President, Investor Relations
636-736-2068
jhopson@rgare.com

Reinsurance Group of America, Incorporated

NYSE:RGA

Release Versions

Contacts

Lynn Phillips
Vice President, Corporate Communications
636-736-2351
lphillips@rgare.com

Lizzie Curry
Director, Public Relations
636-736-8521
lizzie.curry@rgare.com

Jeff Hopson
Senior Vice President, Investor Relations
636-736-2068
jhopson@rgare.com

More News From Reinsurance Group of America, Incorporated

Reinsurance Group of America Names Ryan Krueger Senior Vice President, Investor Relations

ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, announced today that Ryan Krueger will join the company as Senior Vice President, Investor Relations, effective January 5, 2026. In this role, he will lead RGA’s engagement with the investor community, partnering closely with the company’s executive leadership team to articulate RGA’s strategic evolution and performance. Mr. Krueger will report to Executive Vice Presid...

New Research from RGA: GLP-1s Expected to Reduce US Mortality by 3.5% Over the Next 20 Years

ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, published new in-depth research quantifying the mortality and morbidity impacts of incretin-based therapies, including GLP-1s, approved as anti-obesity medications (AOMs) and diabetes treatments. The study examined data from four markets (US, UK, Canada, and Hong Kong) to assess how widespread adoption of AOMs could affect population health outcomes over the next two d...

RGA Announces Opening of First New York City Office at Park Avenue Tower

NEW YORK--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, announced today the opening of its first New York City office. Located in the heart of Midtown Manhattan, Park Avenue Tower combines a prestigious address with a people-first approach to workplace experience. This property exemplifies RGA's broader real estate investment strategy, which focuses on high-quality assets in premier locations that align with both operational...
Back to Newsroom